Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media.
General anesthetics and radiocontrast media (RCM) can cause anaphylactic or anaphylactoid reactions. These are usually underdiagnosed and underreported, but their incidence is apparently rising. Their pathogenesis is complex and not completely understood, but the release of vasoactive mediators from basophils and mast cells plays a central role. The recent development of in vitro techniques to study the release of preformed (histamine and tryptase) and de novo synthesized mediators (PGD2, LTC4, and PAF) from purified basophils and mast cells has made it possible to quantify the mediator-releasing activity of anesthetics such as muscle relaxants, general anesthetics, opioids, and benzodiazepines and RCM on human basophils and mast cells isolated from lung, skin and heart tissues. The majority of general anesthetics and RCM tested induced only the release of preformed mediators (histamine and tryptase), not of the de novo synthesized eicosanoids. There was wide variability in the response of basophils and mast cells from different donors to the same drug or RCM, presumably due to the releasability parameter. Hyperosmolality is probably not the only factor responsible for basophil and mast cell activation by RCM. The in vitro release of histamine induced by anesthetic drugs and RCM was correlated with the release of tryptase. Given the longer half-life of tryptase than histamine in plasma, measurements of plasma tryptase may become a useful diagnostic tool for identifying adverse reactions to anesthetics and RCM.
Genovese
A
A
Division of Clinical Immunology and Allergy, University of Naples Federico II, School of Medicine, Italy.
Stellato
C
C
Marsella
C V
CV
Adt
M
M
Marone
G
G
D018681:Anesthetics, General / Q000009:adverse effects*; D001491:Basophils / Q000187:drug effects / Q000502:physiology*; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D017997:Leukotriene C4 / Q000502:physiology; D008407:Mast Cells / Q000187:drug effects / Q000502:physiology*; D010972:Platelet Activating Factor / Q000502:physiology; D015230:Prostaglandin D2 / Q000502:physiology
D018681:Anesthetics, General; D003287:Contrast Media; D010972:Platelet Activating Factor; D017997:Leukotriene C4; D015230:Prostaglandin D2